5 terminated. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Terminated 5 |
Follow Obsessive-Compulsive Disorder: new trials by email Literature Review of Obsessive-Compulsive Disorder trials Research Report on Obsessive-Compulsive Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDAS Naproxen Sodium, Placebo - PANDAS, Anxiety Disorder | Phase 4 | Terminated | Massachusetts General Hospital | 2 | 2020-10-20 | 2026-05-20 |
| Probiotic Treatment in Adult Obsessive-Compulsive Disorder Probiotic Formula (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175), Placebo - Obsessive-Compulsive Disorder | Phase 4 | Terminated | McMaster University | 15 | 2018-09-01 | 2021-09-10 |
| Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents Fluvoxamine maleate, Placebo - Obsessive Compulsive Disorder | Phase 4 | Terminated | Solvay Pharmaceuticals | 20 | 2006-08-01 | 2010-03-04 |
| Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder fluoxetine - Pediatric Bipolar Disorder, Pediatric OCD | Phase 4 | Terminated | Massachusetts General Hospital | 13 | 2005-12-01 | 2025-01-28 |
| Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders Sertraline, Placebo - Phobia, Social, Panic Disorder | Phase 4 | Terminated | Hamilton Health Sciences Corporation | 170 | 2002-07-01 | 2018-03-22 |
Anxiety Disorders (3) · Agoraphobia (1) · Autoimmune Diseases (1) · Bipolar Disorder (1) · Depressive Disorder, Major (1) · Dysthymic Disorder (1) · Panic Disorder (1) · Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (1) · Phobia, Social (1)
Mental Disorders (5) · Anxiety Disorders (2) · Mood Disorders (2) · Bipolar and Related Disorders (1) · Depressive Disorder (1) · Immune System Diseases (1) · Phobic Disorders (1)
Fluoxetine (1) · Fluvoxamine (1) · Naproxen (1) · Sertraline (1)
Massachusetts General Hospital (2) · Hamilton Health Sciences Corporation (1) · McMaster University (1) · Solvay Pharmaceuticals (1)
Canada (2) · United States (2) · Japan (1)
Michael Van Ameringen, MD, FRCPC (2) · Gagan Joshi, MD (1) · Toshiaki Yamaguchi (1)